Granulocyte colony-stimulating factors

The FDA ( Food and Drug Administration ) has approved Ramucirumab ( Cyramza ) in combination with Paclitaxel as a...


Capillary leak syndrome ( CLS ) has been reported in recipients of Filgrastim, including patients undergoing chemotherapy and a healthy...